Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-31 @ 10:42 AM
Study NCT ID:
NCT05104333
Status:
UNKNOWN
Last Update Posted:
2021-11-03
First Post:
2021-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes
Sponsor:
China National Biotec Group Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-30
First Submit QC Date:
None
Study First Post Date:
2021-11-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-30
Last Update Post Date:
2021-11-03
Last Update Post Date Type:
ACTUAL